These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11823757)

  • 21. Effect of methylprednisolone on CYP3A4-mediated drug metabolism in vivo.
    Villikka K; Varis T; Backman JT; Neuvonen PJ; Kivistö KT
    Eur J Clin Pharmacol; 2001 Sep; 57(6-7):457-60. PubMed ID: 11699609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mibefradil but not isradipine substantially elevates the plasma concentrations of the CYP3A4 substrate triazolam.
    Backman JT; Wang JS; Wen X; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 1999 Oct; 66(4):401-7. PubMed ID: 10546924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-dose pharmacokinetics and pharmacodynamics of oral triazolam in relation to cytochrome P4502C19 (CYP2C19) activity.
    Yasui N; Otani K; Ohkubo T; Osanai T; Sugawara K; Chiba K; Ishizaki T; Kaneko S
    Ther Drug Monit; 1997 Aug; 19(4):371-4. PubMed ID: 9263374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modafinil influences the pharmacokinetics of intravenous cocaine in healthy cocaine-dependent volunteers.
    Donovan JL; DeVane CL; Malcolm RJ; Mojsiak J; Chiang CN; Elkashef A; Taylor RM
    Clin Pharmacokinet; 2005; 44(7):753-65. PubMed ID: 15966757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coadministration of nefazodone and benzodiazepines: II. A pharmacokinetic interaction study with triazolam.
    Barbhaiya RH; Shukla UA; Kroboth PD; Greene DS
    J Clin Psychopharmacol; 1995 Oct; 15(5):320-6. PubMed ID: 8830062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of parecoxib, a parenteral cyclooxygenase-2 specific inhibitor, on the pharmacokinetics and clinical effects of midazolam.
    Ibrahim A; Karim A; Feldman J; Kharasch E
    Anesth Analg; 2002 Sep; 95(3):667-73, table of contents. PubMed ID: 12198057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive.
    Saano V; Glue P; Banfield CR; Reidenberg P; Colucci RD; Meehan JW; Haring P; Radwanski E; Nomeir A; Lin CC
    Clin Pharmacol Ther; 1995 Nov; 58(5):523-31. PubMed ID: 7586946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-dose pharmacokinetics of modafinil and methylphenidate given alone or in combination in healthy male volunteers.
    Wong YN; King SP; Laughton WB; McCormick GC; Grebow PE
    J Clin Pharmacol; 1998 Mar; 38(3):276-82. PubMed ID: 9549666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of triazolam clearance by macrolide antimicrobial agents: in vitro correlates and dynamic consequences.
    Greenblatt DJ; von Moltke LL; Harmatz JS; Counihan M; Graf JA; Durol AL; Mertzanis P; Duan SX; Wright CE; Shader RI
    Clin Pharmacol Ther; 1998 Sep; 64(3):278-85. PubMed ID: 9757151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of effect of rosiglitazone on the pharmacokinetics of oral contraceptives in healthy female volunteers.
    Inglis AM; Miller AK; Culkin KT; Finnerty D; Patterson SD; Jorkasky DK; Freed MI
    J Clin Pharmacol; 2001 Jun; 41(6):683-90. PubMed ID: 11402638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interaction between St John's wort and an oral contraceptive.
    Hall SD; Wang Z; Huang SM; Hamman MA; Vasavada N; Adigun AQ; Hilligoss JK; Miller M; Gorski JC
    Clin Pharmacol Ther; 2003 Dec; 74(6):525-35. PubMed ID: 14663455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition and stimulation of intestinal and hepatic CYP3A activity: studies in humanized CYP3A4 transgenic mice using triazolam.
    van Waterschoot RA; Rooswinkel RW; Sparidans RW; van Herwaarden AE; Beijnen JH; Schinkel AH
    Drug Metab Dispos; 2009 Dec; 37(12):2305-13. PubMed ID: 19752211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of the coadministration of daclatasvir on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and norgestimate.
    Bifano M; Sevinsky H; Hwang C; Kandoussi H; Jiang H; Grasela D; Bertz R
    Antivir Ther; 2014; 19(5):511-9. PubMed ID: 24343001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of in vivo interaction between triazolam and erythromycin based on in vitro studies using human liver microsomes and recombinant human CYP3A4.
    Kanamitsu S; Ito K; Green CE; Tyson CA; Shimada N; Sugiyama Y
    Pharm Res; 2000 Apr; 17(4):419-26. PubMed ID: 10870985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of an oral contraceptive preparation containing ethinylestradiol and gestodene on CYP3A4 activity as measured by midazolam 1'-hydroxylation.
    Palovaara S; Kivistö KT; Tapanainen P; Manninen P; Neuvonen PJ; Laine K
    Br J Clin Pharmacol; 2000 Oct; 50(4):333-7. PubMed ID: 11012556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes.
    Walzer M; Bekersky I; Blum RA; Tolbert D
    Pharmacotherapy; 2012 Apr; 32(4):340-53. PubMed ID: 22422635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic profile of armodafinil in healthy subjects: pooled analysis of data from three randomized studies.
    Darwish M; Kirby M; Hellriegel ET; Yang R; Robertson P
    Clin Drug Investig; 2009; 29(2):87-100. PubMed ID: 19133704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of an oral contraceptive on the plasma levels of budesonide and prednisolone and the influence on plasma cortisol.
    Seidegård J; Simonsson M; Edsbäcker S
    Clin Pharmacol Ther; 2000 Apr; 67(4):373-81. PubMed ID: 10801246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steady-state pharmacokinetics and tolerability of modafinil administered alone or in combination with dextroamphetamine in healthy volunteers.
    Hellriegel ET; Arora S; Nelson M; Robertson P
    J Clin Pharmacol; 2002 Apr; 42(4):450-60. PubMed ID: 11936571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluconazole, but not terbinafine, enhances the effects of triazolam by inhibiting its metabolism.
    Varhe A; Olkkola KT; Neuvonen PJ
    Br J Clin Pharmacol; 1996 Apr; 41(4):319-23. PubMed ID: 8730978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.